Creatine Kinase MB (CK-MB) antibody and antigen (Recombinant protein)
Diagnostic Creatine Kinase MB (CK-MB) antibodies (anti-Creatine Kinase MB, anti-CK-MB) and antigens (recombinant Creatine Kinase MB (CK-MB) protein) for Cardiovascular disease CK-MB detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-CK-MB-Ag01 | Recombinant human CKM/CK-MB/CKMM Protein | 3090 |
GMP-h-CK-MB-Ab01 | Anti-human CKM/CK-MB/CKMM mouse monoclonal antibody (mAb) | 1953 |
GMP-h-CK-MB-Ab02 | Anti-human CKM/CK-MB/CKMM mouse monoclonal antibody (mAb) | 1953 |
GMP-h-CK-MB-Ab03 | Anti-human CKM/CK-MB/CKMM human monoclonal antibody (mAb) | 1953 |
GMP-h-CK-MB-Ab04 | Anti-human CKM/CK-MB/CKMM human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-h-CK-MB-Ag01 |
Product Name | Recombinant human CKM/CK-MB/CKMM Protein |
Target/Biomarker | Creatine Kinase MB(CK-MB) |
Alias of Target/Biomarker | CKMM, CPK-M, M-CK |
Expression platform | mammalian |
Isotypes | Recombinant Antigen |
Bioactivity validation | Creatine Kinase MB (CK-MB) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CK-MB level test of Cardiovascular disease (Myocardial hypoxia) and related syndrome evaluation. |
Products description | Recombinant human CKM/CK-MB/CKMM Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-CK-MB-Ab01, GMP-h-CK-MB-Ab02 |
Product Name | Anti-human CKM/CK-MB/CKMM mouse monoclonal antibody (mAb) |
Target/Biomarker | Creatine Kinase MB(CK-MB) |
Alias of Target/Biomarker | CKMM, CPK-M, M-CK |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Human Creatine Kinase MB (CK-MB) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Creatine Kinase MB (CK-MB) antibodies in CK-MB level test of Cardiovascular disease (Myocardial hypoxia) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human CKM/CK-MB/CKMM mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-CK-MB-Ab03, GMP-h-CK-MB-Ab04 |
Product Name | Anti-human CKM/CK-MB/CKMM human monoclonal antibody (mAb) |
Target/Biomarker | Creatine Kinase MB(CK-MB) |
Alias of Target/Biomarker | CKMM, CPK-M, M-CK |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Human Creatine Kinase MB (CK-MB) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Creatine Kinase MB (CK-MB) antibodies in CK-MB level test of Cardiovascular disease (Myocardial hypoxia) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human CKM/CK-MB/CKMM human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Creatine kinase (CK) and its isoenzyme CK-MB are important tools for the diagnosis of acute myocardial infarction. The content of CK-MB relative to total CK in myocardial cells is variable; it is low in normal myocardium and increased several-fold in hypoxic myocardium.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments